November 22, 2016 - By Hazel Jackson · 0 Comments
Daxor Corp (NYSEMKT:DXR) institutional sentiment is 1 in 2016 Q2. Its the same as in 2016Q1. The ratio has no change, as only 3 institutional investors increased and started new stock positions, while 3 sold and trimmed stock positions in Daxor Corp. The institutional investors in our partner’s database now hold: 151,568 shares, up from 151,208 shares in 2016Q1. Also, the number of institutional investors holding Daxor Corp in their top 10 stock positions was flat from 0 to 0 for the same number . Sold All: 2 Reduced: 1 Increased: 1 New Position: 2.
Daxor Corporation is an investment company with medical instrumentation and biotechnology operations. The company has a market cap of $31.73 million. The Firm engages in the short selling of stock. It currently has negative earnings. The Firm maintains a diversified securities portfolio, which consists primarily of the common and preferred stocks of electric utility companies.
The stock decreased 3.72% or $0.34 on November 21, hitting $8.71. Daxor Corporation (NYSEMKT:DXR) has risen 8.88% since April 20, 2016 and is uptrending. It has outperformed by 4.32% the S&P500.
According to Zacks Investment Research, “Daxor Corporation is a medical device manufacturing corporation with additional biotech services.”
Blackrock Fund Advisors holds 0% of its portfolio in Daxor Corporation for 131 shares. California Public Employees Retirement System owns 13,700 shares or 0% of their US portfolio. Moreover, Deutsche Bank Ag has 0% invested in the company for 54 shares. The New York-based Renaissance Technologies Llc has invested 0% in the stock. Tower Research Capital Llc (Trc), a New York-based fund reported 1,290 shares.#img1#
Daxor Corporation, incorporated on May 5, 1971, is an investment firm with medical instrumentation and biotechnology operations. The Firm engages in the short selling of stock. The Firm maintains a diversified securities portfolio, which consists primarily of the common and preferred stocks of electric utility companies. The Firm has approximately 70 Blood Volume Analyzers (BVA)-100. It also sells Volumex Kits. The Company’s IDANT division provides semen banking services, which include anonymous donor semen and semen storage; autologous blood storage; andrology services, which include semen analysis and sperm washing, and general lab testing.
More important recent Daxor Corporation (NYSEMKT:DXR) news were published by: Marketwired.com which released: “Daxor Corporation Announces Hiring of Chief Financial Officer” on June 17, 2016, also Marketwired.com published article titled: “Daxor Corporation Announces Filing of Form N-CSR for December 31, 2014”, Nypost.com published: “Sperm bank accused of discarding hazardous materials” on July 17, 2015. More interesting news about Daxor Corporation (NYSEMKT:DXR) was released by: Nasdaq.com and their article: “Weekly 3-Year Low Stocks: PBR, NJ, DWA, DXR” with publication date: February 11, 2013.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Hazel Jackson